Short Summary
ITC Limited appealed against an order from the Assistant Controller of Patents and Designs which rejected a post-grant opposition against Patent No. IN319780, thereby maintaining the patent. The Appellant argued that the impugned order was non-speaking and unreasoned. Both parties consented to the matter being remanded.
Detailed Summary
In the world of intellectual property, a patent isn't just a piece of paper—it's a fortress around an invention. But what happens when the very authorities entrusted with protecting that fortress issue a ruling without explaining their reasoning? For ITC Limited, one of India's largest conglomerates, this question became a multi-year legal headache when it challenged a patent held by global tobacco giant Philip Morris Products S.A. The case didn't hinge on the merits of the invention itself. Instead, it struck at something far more fundamental: the right to know why a decision was made against you.
ITC Limited, a diversified Indian conglomerate with interests spanning FMCG, hospitality, and agribusiness, found itself in a legal showdown with Philip Morris Products S.A. and others over Patent No. IN319780. The dispute arose after ITC filed a post-grant opposition—a formal challenge to a patent after it had already been granted. This is a critical mechanism in patent law, allowing interested parties to contest patents they believe should never have been granted. The Assistant Controller of Patents and Designs, the quasi-judicial authority responsible for adjudicating such oppositions, ultimately rejected ITC's opposition, thereby maintaining the patent in favor of Philip Morris. Dissatisfied with this outcome, ITC Limited appealed the decision, setting the stage for a higher court review.
ITC Limited's argument was sharp and procedural but devastating in its implications. The company contended that the order passed by the Assistant Controller of Patents and Designs was a non-speaking order—meaning it lacked any reasoning or explanation for why the opposition was rejected. In essence, ITC was told 'no' without being told 'why.' For a party whose legal rights were being directly affected, this was a serious breach of the principles of natural justice. On the other side, Philip Morris Products S.A. and the other respondents had their own stake in defending the patent's validity. Rather than litigate the procedural issue further, both parties found common ground: they consented to the matter being remanded—sent back to the lower authority for a fresh, properly reasoned decision.
The court accepted the consent of both parties and remanded the case back to the Assistant Controller of Patents and Designs. This meant the entire post-grant opposition proceeding would be reconsidered, with the expectation that a proper, speaking order—one that articulates its reasoning—would be issued. The court's decision underscored a vital principle: quasi-judicial and administrative authorities cannot issue orders that affect the rights of parties without providing clear, reasoned explanations. A silent order is no order at all when it comes to justice.
For founders, startup leaders, and IP professionals, this case delivers a powerful lesson: when dealing with any government or quasi-judicial authority—whether it's a patent office, trademark registry, or regulatory body—demand reasoned decisions. If an authority rules against you, you have every right to expect a well-articulated explanation. Non-speaking orders are vulnerable to challenge and remand, wasting time and resources. More importantly, when filing oppositions or appeals, always scrutinize the procedural integrity of the orders you receive. A decision without reasoning is not just frustrating—it's legally indefensible. In IP disputes, the process matters as much as the outcome.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in ITC Limited vs Philip Morris Products S.A. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Mr Imran Aman Sharieff (IAS Enterprises)vsM/s Sathwika Traders; M/s Sri Tarakarama Rice Industries
The Karnataka High Court remanded an appeal concerning a dispute over trademark and copyright infringement. The appellant, Mr. Imran Aman Sharieff, sought to overturn the trial court's rejection of his application for a temporary injunction. Crucially, he introduced a new document—an order rejecting the respondents' trade mark registration application—at the appellate stage. The High Court ruled that since this new evidence was not available during the initial proceedings, it could only be used by directing the trial court to reconsider its decision based on the newly produced material.
F.Hoffmann-La Roche AgvsAssistant Controller of Patents and Designs, Government of India
F.Hoffmann-La Roche Ag appealed an order rejecting its patent application for a subcutaneous anti-HER2 antibody formulation. The rejection was based on the product lacking inventive step and being known in the market. The court allowed the appeal, noting that the original decision failed to address 11 out of 12 claims independently.
UCB Pharma GMBHvsThe Controller of Patents and Designs
UCB Pharma appealed an order refusing to proceed with its patent application for a solid dispersion formulation of Rotigotine. The court found that the Controller had caused inordinate delays and violated statutory timelines, compounded by citing new prior art documents at the hearing without proper notification. Consequently, the impugned order was set aside and the matter was remanded for fresh consideration.
Jesal Vimal JethavsController General Of Patents, Designs and Trade Marks
The appeal challenged the Controller's refusal of a patent application for a customizable comforter system, citing failure to meet objections under Section 2(1)(ja). The appellant argued that the decision was mechanical and violated natural justice due to procedural irregularities in handling prior art documents. The High Court set aside the order and remanded the matter for fresh consideration.
Boehringer Ingelheim Pharma Gmbh And Co. Kg & Anr.vsVee Excel Drugs and Pharmaceuticals Private Ltd. & Ors., Alkem Laboratories Ltd & Anr., Micro Labs Limited, Natco Pharma Limited & Anr., Mankind Pharma Limited
Boehringer Ingelheim Pharma sought permanent injunctions against various Indian pharmaceutical companies, alleging infringement of Patent No. IN 243301 related to Linagliptin tablets. The Delhi High Court examined the applications for interim injunction across multiple connected suits. The court found that the plaintiffs failed to establish a prima facie case, noting concerns about potential patent vulnerability due to prior claiming and attempts at evergreening. Consequently, all interim injunction applications were dismissed, allowing defendants to continue manufacturing and selling the products.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.